Evidence map›Paper›PMID 30736814›Full record

ArticleVirology journal2019

Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation.

Ling Zhou, Dao-Pei Lu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ling ZhouThe Fifth People's Hospital of Shanghai, Fudan University, No. 801 Heqing Road, Minhang County, Shanghai, 200240, China. ling-zhou@tom.com.
Dao-Pei LuThe Fifth People's Hospital of Shanghai, Fudan University, No. 801 Heqing Road, Minhang County, Shanghai, 200240, China.
Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHaploidentical hematopoietic stem cell transplant (haplo-HSCT) recipients are at high risk for Epstein Barr virus (EBV)-related diseases. EBV-specific CD8

methodsHLA-A*1101 and HLA-A*0201 pentamers folded with immunodominant EBV peptides were used to detect EBV-specific CD8

resultsPentamer-binding EBV-specific CD8

conclusionsHaplo-HSCT recipients could generate EBV-specific CD8

Indexed as

Hematopoietic Stem Cell TransplantationImmune ReconstitutionAdolescentAdultChildChild, PreschoolEpstein-Barr Virus InfectionsFemaleHerpesvirus 4, HumanHLA-A11 AntigenHLA-A2 AntigenHumansMaleMiddle AgedProspective StudiesT-Lymphocytes, CytotoxicHLA-A*02:01 antigenHLA-A*11:01 antigenHLA-A11 AntigenHLA-A2 AntigenCD8 cellsEpstein-Barr virusHaploidentical hematopoietic stem cell transplantationPentamers

Identifiers

PMID30736814
PMCPMC6368816
OpenAlexW2918437785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.